Survodutide, a dual GLP-1 and glucagon receptor agonist, significantly reduced body weight in adults with obesity in the SYNCHRONIZE-1 trial.

A new proposal could make it easier for many patients to access breakthrough medical devices through Medicare.

A greater number of live births is associated with a decreased risk for stroke years later, according to a new study.

Individuals with screening-detected AF have a comparable risk for developing heart failure to those with clinically known AF.

Coramitug is currently being investigated in the phase 3 CLEOPATTRA trial in approximately 1280 patients with ATTR-CM.

Olezarsen significantly lowers triglycerides and pancreatitis risk in severe hypertriglyceridemia, with a favorable short-term safety profile.

Topline results from the pivotal HAELO trial demonstrate that a single infusion of lonvo-z significantly reduces HAE attacks and the need for chronic prophylactic therapy.

For patients with early infection with Lyme disease, standard and modified two-tiered testing diagnostic algorithms have low sensitivity.

Patients who develop myocarditis within the first month of receiving immune checkpoint inhibitor therapy are more likely to have MC fatality.

Major medical and CV journals significantly underrepresent African countries in randomized controlled trials, compared with disease burden.

Hypertension is common among post-9/11 veterans, with clinical hypertension seen in 44.9%, according to a study.

For adults with T2D, a ketogenic diet (KD) reduces the proportion of proinsulin secreted to a greater extent than a low-fat diet (LFD).